Please try another search
New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People’s Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The company is also involved in the research and development of medical diagnostic technology; provision of technical services, transfers, and consultation; and medical services, as well as financing services; manufacturing and sales of medical and laboratory equipment, and fecal occult blood test kits; and technological import and export activities. The company was founded in 2015 and is headquartered in Hangzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Naxin Yao | 50 | 2018 | Non-executive Director |
Hong Wu | 63 | 2021 | Independent Non-executive Director |
Danke Yu | 52 | 2021 | Independent Non-executive Director |
Kwok Tung Li | 68 | 2021 | Independent Non-executive Director |
Yeqing Zhu | 50 | 2018 | CEO, Executive Chairman & Co-founder |
Yiyou Chen | 51 | 2018 | Executive Director & Chief Scientific Officer |
Ngai Kee Lau | 56 | 2024 | Independent Non-Executive Director |
Weng Sin Ng | 52 | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review